Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease V: Surgical Management

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying Patients at Elevated Risk of Stroke After Transcarotid Artery Revascularization

Journal of vascular surgery·2026

Same author

Is 5.5 cm Still the Optimal Size Threshold to Treat AAA in Men? A Contemporary Cost-Utility Analysis.

Annals of surgery·2026

Same author

Use of pharmacologic guideline-directed medical therapy for peripheral artery disease by sex among patients undergoing revascularization.

Journal of vascular surgery·2026

Same author

Utilization of the stop-short technique in transcarotid artery revascularization is associated with intraoperative common carotid artery dissection.

Journal of vascular surgery·2026

Same author

Instrumental variable estimation of a hazard ratio for treatment with a waiting time without specifying its dependence on unmeasured confounders: application to a procedural registry.

Lifetime data analysis·2026

Same author

"Textbook Outcome" in Endovascular Aortic Repair is Associated With Improved One-year Survival.

Annals of surgery·2026

Same journal

Sudden Cardiac Arrest and Takotsubo-Like Cardiomyopathy as the Initial Presentation of Primary Carnitine Deficiency.

JACC. Case reports·2026

Same journal

Secondary Cardiac Lymphoma Presenting as Effusive-Constrictive Pericarditis.

JACC. Case reports·2026

Same journal

Left Ventricular Outflow Tract Rupture in a Case of Pediatric Bicuspid Aortic Valve Endocarditis.

JACC. Case reports·2026

Same journal

Lyme Myopericarditis With Effusive-Constrictive Physiology: Serial CMR Identifies a Reversible Inflammatory Phenotype.

JACC. Case reports·2026

Same journal

Transcatheter Edge-to-Edge Repair of a Functionally Trileaflet Mitral Valve.

JACC. Case reports·2026

Same journal

Managing Rheumatic Mitral Stenosis Complicated by Shock and Cardiac Cirrhosis Beyond Guidelines.

JACC. Case reports·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

Revascularization in a Time After CORAL.

Anne R Dionne¹, Jesse A Columbo^1,2, Clay Block^1,3

¹Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA.

JACC. Case Reports

|October 3, 2024

Summary

This summary is machine-generated.

Revascularization for renal artery stenosis is less common, but may benefit elderly patients with severe disease and complications like pulmonary edema. This case highlights potential benefits in a high-risk phenotype often excluded from clinical trials.

Area of Science:

Cardiology
Nephrology
Vascular Medicine

Background:

Randomized controlled trials (RCTs) have reduced the use of renal artery revascularization in renal artery stenosis (RAS).

Keywords:

hypertension stenosis stents vascular disease

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

These RCTs primarily focused on low-risk patients, excluding those with severe phenotypes.

High-grade RAS can lead to severe complications like acute pulmonary edema and progressive kidney disease.